Proinflammatory activation pattern of human umbilical vein endothelial cells induced by IL‐1β, TNF‐α, and LPS V Makó, J Czúcz, Z Weiszhár, E Herczenik, J Matkó, Z Prohászka, ... Cytometry Part A 77 (10), 962-970, 2010 | 222 | 2010 |
Complement protease MASP-1 activates human endothelial cells: PAR4 activation is a link between complement and endothelial function M Megyeri, V Makó, L Beinrohr, Z Doleschall, Z Prohászka, L Cervenak, ... The Journal of Immunology 183 (5), 3409-3416, 2009 | 170 | 2009 |
Studies on the interactions between C‐reactive protein and complement proteins A Bíró, Z Rovó, D Papp, L Cervenak, L Varga, G Füst, NM Thielens, ... Immunology 121 (1), 40-50, 2007 | 160 | 2007 |
Increased serum heat-shock protein 70 levels reflect systemic inflammation, oxidative stress and hepatocellular injury in preeclampsia A Molvarec, J Rigó Jr, L Lázár, K Balogh, V Makó, L Cervenak, M Mézes, ... Cell Stress and Chaperones 14 (2), 151-159, 2009 | 139 | 2009 |
Complement overactivation and consumption predicts in-hospital mortality in SARS-CoV-2 infection G Sinkovits, B Mező, M Réti, V Müller, Z Iványi, J Gál, L Gopcsa, ... Frontiers in immunology 12, 663187, 2021 | 119 | 2021 |
Multiple roles of complement MASP-1 at the interface of innate immune response and coagulation J Dobó, V Schroeder, L Jenny, L Cervenak, P Závodszky, P Gál Molecular immunology 61 (2), 69-78, 2014 | 117 | 2014 |
Abolished angiogenicity and tumorigenicity of Burkitt lymphoma by interleukin-10 L Cervenak, L Morbidelli, D Donati, S Donnini, T Kambayashi, JL Wilson, ... Blood, The Journal of the American Society of Hematology 96 (7), 2568-2573, 2000 | 113 | 2000 |
The emerging roles of mannose‐binding lectin‐associated serine proteases (MASP s) in the lectin pathway of complement and beyond J Dobó, G Pál, L Cervenak, P Gál Immunological reviews 274 (1), 98-111, 2016 | 106 | 2016 |
Differential expression of GL7 activation antigen on bone marrow B cell subpopulations and peripheral B cells L Cervenak, A Magyar, R Boja, G László Immunology letters 78 (2), 89-96, 2001 | 96 | 2001 |
Increased plasma von Willebrand factor antigen levels but normal von Willebrand factor cleaving protease (ADAMTS13) activity in preeclampsia A Molvarec, J Rigó Jr, T Bõze, Z Derzsy, L Cervenak, V Makó, T Gombos, ... Thrombosis and haemostasis 101 (02), 305-311, 2009 | 94 | 2009 |
Caveolae—an alternative endocytotic pathway for targeted drug delivery G Bathori, L Cervenak, I Karadi Critical Reviews™ in Therapeutic Drug Carrier Systems 21 (2), 2004 | 92 | 2004 |
Antibodies against different epitopes of heat-shock protein 60 in children with type 1 diabetes mellitus L Horváth, L Cervenak, M Oroszlan, Z Prohászka, K Uray, F Hudecz, ... Immunology Letters 80 (3), 155-162, 2002 | 83 | 2002 |
Modified low density lipoproteins differentially bind and activate the C1 complex of complement A Biró, NM Thielens, L Cervenák, Z Prohászka, G Füst, GJ Arlaud Molecular Immunology 44 (6), 1169-1177, 2007 | 80 | 2007 |
FcRn mediates elongated serum half-life of human IgG in cattle I Kacskovics, Z Kis, B Mayer, AP West Jr, NE Tiangco, M Tilahun, ... International immunology 18 (4), 525-536, 2006 | 79 | 2006 |
Levels of antibodies against C1q and 60 kDa family of heat shock proteins in the sera of patients with various autoimmune diseases L Horvath, L Czirjak, B Fekete, L Jakab, Z Prohaszka, L Cervenak, ... Immunology letters 75 (2), 103-109, 2001 | 73 | 2001 |
“Nuts and bolts” of laboratory evaluation of angioedema H Farkas, N Veszeli, E Kajdácsi, L Cervenak, L Varga Clinical reviews in allergy & immunology 51, 140-151, 2016 | 71 | 2016 |
Relationship of circulating cell-free DNA levels to cell-free fetal DNA levels, clinical characteristics and laboratory parameters in preeclampsia L Lazar, J Rigó, B Nagy, K Balogh, V Makó, L Cervenak, M Mézes, ... BMC medical genetics 10, 1-6, 2009 | 70 | 2009 |
Identification and validation of compounds selectively killing resistant cancer: delineating cell line–specific effects from P-glycoprotein–induced toxicity A Füredi, S Tóth, K Szebényi, VFS Pape, D Türk, N Kucsma, L Cervenak, ... Molecular Cancer Therapeutics 16 (1), 45-56, 2017 | 57 | 2017 |
MASP-1 induces a unique cytokine pattern in endothelial cells: a novel link between complement system and neutrophil granulocytes PK Jani, E Kajdacsi, M Megyeri, J Dobo, Z Doleschall, K Futosi, CI Tímár, ... PloS one 9 (1), e87104, 2014 | 57 | 2014 |
Levels of von Willebrand factor antigen and von Willebrand factor cleaving protease (ADAMTS13) activity predict clinical events in chronic heart failure T Gombos, V Makó, L Cervenak, J Papassotiriou, J Kunde, J Hársfalvi, ... Thrombosis and haemostasis 102 (09), 573-580, 2009 | 55 | 2009 |